TickerFactsScreenerDevelopers

Sarepta Therapeutics, Inc. (SRPT) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: -$8.80M2010: -$15.21M2011: -$23.68M2012: -$29.69M2016: -$245.82M2017: -$232.00M2018: -$388.66M2019: -$456.46M2020: $107.47M2021: -$443.17M2022: -$325.35M2023: -$500.99M2024: -$205.79M2025: -$205.48M-$205.48M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$205.48M+0.1%
2024-$205.79M+58.9%
2023-$500.99M-54.0%
2022-$325.35M+26.6%
2021-$443.17M-512.4%
2020$107.47M+123.5%
2019-$456.46M-17.4%
2018-$388.66M-67.5%
2017-$232.00M+5.6%
2016-$245.82M—
2012-$29.69M-25.4%
2011-$23.68M-55.7%
2010-$15.21M-72.8%
2009-$8.80M—